2017
DOI: 10.1038/pr.2017.235
|View full text |Cite
|
Sign up to set email alerts
|

Effects of iron supplementation of low-birth-weight infants on cognition and behavior at 7 years: a randomized controlled trial

Abstract: BackgroundLow-birth-weight infants (LBW) are at an increased risk of iron deficiency that has been associated with impaired neurodevelopment. We hypothesized that iron supplementation of LBW infants improves cognitive scores and reduces behavioral problems until school age.MethodsWe randomized 285 marginally LBW (2,000-2,500 g) infants to receive 0, 1, or 2 mg/kg/day of iron supplements from 6 weeks to 6 months of age. At 7 years of age, 205 participants were assessed regarding cognition using Wechsler Intelli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
52
1
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(55 citation statements)
references
References 34 publications
0
52
1
2
Order By: Relevance
“…Moreover, studies have reported elevated total, internalizing, and/or externalizing problem scores in children born PT compared with FT peers (2) and that higher levels of internalizing difficulties may be a particular and long-lasting characteristic in children born at lower GA in the 1990s−2000s (4,8,14,15,41). Recently, an increased risk of externalizing problems at 7 years of age in infants with marginally low birth weight (of which most were moderately/late preterm) has been described-a risk that may be minimized by preventing iron deficiency (42). We have no individual data of iron intake in the current study, but iron supplementation was generally recommended for infants born PT with birth weight <2,500 g. No effect of group on total problem score and no specific pattern regarding internalizing or externalizing problems in the PT group could be discerned in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, studies have reported elevated total, internalizing, and/or externalizing problem scores in children born PT compared with FT peers (2) and that higher levels of internalizing difficulties may be a particular and long-lasting characteristic in children born at lower GA in the 1990s−2000s (4,8,14,15,41). Recently, an increased risk of externalizing problems at 7 years of age in infants with marginally low birth weight (of which most were moderately/late preterm) has been described-a risk that may be minimized by preventing iron deficiency (42). We have no individual data of iron intake in the current study, but iron supplementation was generally recommended for infants born PT with birth weight <2,500 g. No effect of group on total problem score and no specific pattern regarding internalizing or externalizing problems in the PT group could be discerned in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical trials that assess traditional supplementation as a single-nutrient oral dose are limited and are primarily conducted in low-income countries with high levels of IDA. These supplementation studies found that daily, oral iron supplementation between 6 and 12 months reduced the risk of IDA in infancy [292][293][294][295][296][297] and improved psychomotor development scores in anemic babies at 12 months old [293]. However, there was no significant neurocognitive improvement reported in iron-replete babies at 9 months [294] [297].…”
Section: Ironmentioning
confidence: 99%
“…The research indicates the most significant benefits of iron supplementation are seen in high-risk groups [70,292] with infants who have, or are at high-risk for, IDA [293,296], or who live in areas where there is a high prevalence of iron deficiency [70]. All current research agrees the relationship between iron, general development, and neurocognitive development is not fully understood, and further research is needed [70,[292][293][294][295][296][297].…”
Section: Ironmentioning
confidence: 99%
“…This MA did not identify any studies comparing iron supplementation to placebo for neurodevelopmental outcomes and one study was identified that showed no difference in neurodevelopment between high- and low-dose iron but a higher incidence of an abnormal neurological examination at 5 years of age with late-onset supplementation of iron ( Mills & Davies, 2012 ). Child behaviour but not intelligence scores were reported in one RCT as significantly better at seven-year follow-up of LBW infants supplemented with iron from birth compared with unsupplemented infants ( Berglund et al, 2018 ).…”
Section: Resultsmentioning
confidence: 99%